Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women
1 other identifier
observational
150
1 country
1
Brief Summary
This study will evaluate the prevalence of diastasis m. rectus abdominis after delivery. Relationship of Diastasis Recti Abdominis with urine leakage, pelvic floor muscle function and morphometry in postpartum women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2021
CompletedFirst Submitted
Initial submission to the registry
September 10, 2021
CompletedFirst Posted
Study publicly available on registry
September 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 23, 2022
CompletedJuly 7, 2022
July 1, 2022
1.1 years
September 10, 2021
July 4, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of Diastasis Recti Abdominis in Postpartum Women.
IRD distance measured by a linear probe 2D usg, 4.5 cm above the navel, 4.5 cm below the navel. At rest, and when raising the lower limbs.
Six weeks to up to 6 months after birth
Secondary Outcomes (2)
Relationship of Diastasis Recti Abdominis with urine leakage, pelvic floor muscle function and morphometry in postpartum women.
Six weeks to up to 6 months after birth.
Relationship between Diastasis Recti Abdominis and back pain in postpartum women.
Six weeks to up to 6 months after birth.
Interventions
IRD distance measured by a linear probe 2D usg. Pelvic floor muscle morphometry measured by 3D/4D usg
Eligibility Criteria
Women from six weeks to up to 6 months after birth, age over 18 years old.
You may qualify if:
- Women from six weeks to up to 6 months after birth, age over 18 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PJ Safarik University
Košice, 04011, Slovakia
Study Officials
- PRINCIPAL INVESTIGATOR
Rastislav Dudič, PhD
Department of Gynecology and Obstetrics, Medical Faculty, PJ Safarik University, Kosice, Slovakia
- STUDY DIRECTOR
Magdalena Hagovska, Prof,PhD
KFBLR, Medical Faculty, PJ Safarik University, Kosice, Slovakia
- STUDY DIRECTOR
Jan Svihra, Prof,MD,PhD.
Department of Urology, Institution, Comenius University Bratislava, Slovakia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Faculty of Medicine
Study Record Dates
First Submitted
September 10, 2021
First Posted
September 21, 2021
Study Start
April 8, 2021
Primary Completion
April 28, 2022
Study Completion
May 23, 2022
Last Updated
July 7, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share